undamentalytics Newsletter

Trier Clayton: insider trades

Director at U S Physical Therapy Inc. No open-market purchases and 19 sales not made under a pre-set plan, reported from March 22, 2011 to November 12, 2024.

What happened after Trier Clayton’s sales?

After their sales, the shares moved −2.8% against the index over 12 months on average (a negative figure means selling was the right call); 58% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Trier Clayton: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 19 +0.5% +1.9% 47% 13 0.16 0.87 No reliable evidence
Sales, 12 months after the report 19 −2.8% −2.8% 58% 13 −0.14 0.89 No reliable evidence
Sales, 12 months after the trade 19 −2.6% −4.5% 58% 12 −0.25 0.80 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
U S Physical Therapy Inc USPH —019March 22, 2011November 12, 2024

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
November 12, 2024November 8, 2024 USPH Sale $191,560 −6.0%−34.4%−37.6%
March 14, 2024March 13, 2024 USPH Sale $42,800 −17.5%−39.6%−38.8%
December 14, 2023December 13, 2023 USPH Sale $107,944 +12.9%−21.2%−27.8%
March 6, 2023March 3, 2023 USPH Sale $37,995 +6.0%−19.7%−24.6%
December 5, 2022December 1, 2022 USPH Sale $242,431 +7.4%−16.5%−13.2%
June 4, 2021June 2, 2021 USPH Sale $299,785 −9.1%−2.8%−5.4%
May 27, 2021May 26, 2021 USPH Sale $24,060 −6.6%−0.3%−1.4%
August 14, 2019August 13, 2019 USPH Sale $506,962 −24.2%−53.5%−49.6%
August 20, 2018August 17, 2018 USPH Sale $144,375 +5.8%+13.9%+15.5%
December 12, 2017December 12, 2017 USPH Sale $305,872 +11.5%+53.8%+56.1%
December 31, 2015December 29, 2015 USPH Sale $248,535 −9.2%+23.2%+20.3%
March 10, 2015March 9, 2015 USPH Sale $146,412 +6.7%+12.8%+18.2%
December 3, 2014December 2, 2014 USPH Sale $128,342 +12.3%+24.1%+29.2%
November 12, 2014November 11, 2014 USPH Sale $39,910 −0.3%+25.9%+25.7%
May 29, 2013May 24, 2013 USPH Sale $184,283 −0.9%+1.4%+1.3%
September 28, 2012September 27, 2012 USPH Sale $28,030 −1.9%−2.9%−4.5%
July 2, 2012June 29, 2012 USPH Sale $141,470 +1.9%−8.5%−6.7%
March 26, 2012March 23, 2012 USPH Sale $67,668 +10.7%+2.7%+7.7%
March 22, 2011March 22, 2011 USPH Sale $42,722 +9.5%−12.4%−13.6%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Trier Clayton traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.